---
title: "Top 10 美股涨幅（2月24日）"
description: "Clarivate(CLVT) 涨 39.88%，成交额 9999.4 万美元，年内累计跌 29.6%。 Palvella Therapeutics(PVLA) 涨 37.08%，成交额 1.4 亿美元，年内累计涨 15%。 Iovance 生物治疗 (IOVA) 涨 30.8%，成交额 2.5 亿美元，年内累计涨 38.5%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276793214.md"
published_at: "2026-02-24T22:01:02.000Z"
---

# Top 10 美股涨幅（2月24日）

> Clarivate(CLVT) 涨 39.88%，成交额 9999.4 万美元，年内累计跌 29.6%。 Palvella Therapeutics(PVLA) 涨 37.08%，成交额 1.4 亿美元，年内累计涨 15%。 Iovance 生物治疗 (IOVA) 涨 30.8%，成交额 2.5 亿美元，年内累计涨 38.5%。

纳斯达克综合指数涨 1.04%，年内累计跌 1.6%；标普 500 指数涨 0.77%，年内累计涨 0.7%；道琼斯指数涨 0.76%，年内累计涨 2.3%。

Clarivate(CLVT) 涨 39.88%，成交额 9999.4 万美元，年内累计跌 29.6%。

Palvella Therapeutics(PVLA) 涨 37.08%，成交额 1.4 亿美元，年内累计涨 15%。

Iovance 生物治疗 (IOVA) 涨 30.8%，成交额 2.5 亿美元，年内累计涨 38.5%。

### Related Stocks

- [CLVT.US - Clarivate](https://longbridge.com/zh-CN/quote/CLVT.US.md)
- [PVLA.US - Palvella Therapeutics](https://longbridge.com/zh-CN/quote/PVLA.US.md)
- [IOVA.US - Iovance生物治疗](https://longbridge.com/zh-CN/quote/IOVA.US.md)
- [VIR.US - Vir Biotechnology](https://longbridge.com/zh-CN/quote/VIR.US.md)
- [AXTI.US - AXT公司](https://longbridge.com/zh-CN/quote/AXTI.US.md)
- [KEYS.US - 是德科技](https://longbridge.com/zh-CN/quote/KEYS.US.md)
- [IBRX.US - ImmunityBio](https://longbridge.com/zh-CN/quote/IBRX.US.md)
- [UCTT.US - 超科林半导体](https://longbridge.com/zh-CN/quote/UCTT.US.md)
- [GRAL.US - GRAIL](https://longbridge.com/zh-CN/quote/GRAL.US.md)
- [HLX.US - 螺旋能源解决方案](https://longbridge.com/zh-CN/quote/HLX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Are Wall Street Analysts Predicting Keysight Technologies Stock Will Climb or Sink? | Are Wall Street Analysts Predicting Keysight Technologies Stock Will Climb or Sink? | [Link](https://longbridge.com/zh-CN/news/276353077.md) |
| Palvella Therapeutics (PVLA) Surges On Positive Phase 3 QTORIN SELVA Data | Palvella Therapeutics (NASDAQ:PVLA) shares surged 33.23% to $118.01 following positive topline data from its Phase 3 SEL | [Link](https://longbridge.com/zh-CN/news/276758655.md) |
| NEOS Investment Management LLC Raises Stake in Keysight Technologies Inc. $KEYS | NEOS Investment Management LLC increased its stake in Keysight Technologies Inc. by 44.3% in Q3, now holding 18,730 shar | [Link](https://longbridge.com/zh-CN/news/276440516.md) |
| Exploring Keysight Techs's Earnings Expectations | Keysight Technologies (NYSE: KEYS) is set to announce its quarterly earnings on February 23, 2026, with analysts predict | [Link](https://longbridge.com/zh-CN/news/276450210.md) |
| IOVANCE BIOTHERAPEUTICS, INC. SEC 10-K Report | Iovance Biotherapeutics, Inc. has released its 2025 Form 10-K report, highlighting a total product revenue of $263.5 mil | [Link](https://longbridge.com/zh-CN/news/276753711.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。